Numerous studies have also explored the intriguingly complex roles of both STC1 and STC2, identifying them as potential universal tumor biomarkers and promising therapeutic targets across various cancers, including those affecting female reproductive tissues (47, 48). This evidence concerns the gene STC1 and neoplasm.